Veterinary dermatologists are notably qualified in diagnosing and operating infectious skin diseases such as bacterial, fungal, and viral in animals. Many animals across the world suffer from severe diseases including parasitic skin diseases, dander-related skin disorders, alopecia, intrinsic skin infections, autoimmune skin diseases, mild and harmful skin cancer, hormonal-related skin diseases, and other internal causes for skin abnormalities. Advancements in medical devices and increasing research sources for veterinary dermatologists to diagnose and treat such severe diseases are proving beneficial for pets, pet owners, and other animals. Thus, the rise in veterinary visits is contributing to the growth of the global veterinary dermatology drugs market during the forecast period.
Presently, more than 20% of all animal veterinary meetings are associated with dermatological problems. The most commonly diagnosed dermatological conditions are allergies, otitis externa, seborrhoeic dermatitis, and surface pyoderma. The market still demands tremendous improvement in the animal dermatology sector and hence, there is a progress in discovering new drugs for the veterinary service. With safety and efficacy studies being developed, there is notable advancements made for equine lameness and the manufacturers are focusing on increasing the production and distribution of the drugs, helping horses globally. Recently, innovations in equine dermatological drugs are helping with common diseases such as skin inflammation. fungal infection, or an infectious bacterium in horses. As disorders are very common in horses across the world, there is a heavy demand for the veterinary dermatology drugs market and is expected to grow in the upcoming future.
The effects of the COVID-19 pandemic on the veterinary profession has been unexpected, far-reaching, and diverse. Across many countries, veterinary dermatology practices have made enormous changes to assure patients continue to receive crucial veterinary care, and new safety standards are achieved to protect staff and clients. Veterinary experts have implemented a variety of operational strategies and prudent measures to continue giving veterinary care, while restricting the spread of the coronavirus and prioritizing safety.
The COVID-19 pandemic continues its attack on the world and the veterinary profession, and it is expected to affect the global veterinary dermatology drugs market until the end of 2021. However, as precautionary measures, clients are being asked to wait in vehicles during animal exams and treatment. Other operational developments include contactless payment processing, transferring patient data online, and drive-thru pick-up and drop-off. However, due to constraints in the supply chain and manufacturing units due to limited workforce and stringent regulations, the market is experiencing slow growth amidst the pandemic. Nevertheless, rapid distribution of vaccines and improved medical care are expected to drive the global veterinary dermatology drugs market growth rate shortly.
As compared to some common diseases in humans and animals such as mycoses, mycotic diseases in animals have gained much less consideration. This is unusual, as dermatophytes acting as agents of infectious diseases in animals is one of the oldest recognized disorders in animals. The dermatophytes are responsible for several zoonotic infections, and it is estimated to account for 80% of human skin diseases through animals. However, recent innovations in animal medications and treatments are efficient in the cure of such diseases. Moreover, manufacturers are focusing on research and development to avoid dermatophytes and infections related to it. These innovations are likely to attract various pet owners to the veterinary dermatology drugs market during the forecast period.
Presently, numerous antifungal drugs are used to treat skin diseases in animals. Based on the fungus and animals, the veterinarian prescribes the drug for the treatment. Although griseofulvin is the single antifungal recommended for systemic treatment by the Food and Drug Administration (FDA) for veterinary use, a variety of systemic antifungals are available for use in veterinary medicine. With rise of generic formulations, various cost-efficient drugs can be found in the current market. The appearance of immunity in fungal organisms has influenced various producers for the development of newer antifungals such as itraconazole, fluconazole, voriconazole, and posaconazole. The effective and improved treatment options are driving the global veterinary dermatology drugs market in the near future.
The veterinary dermatology drugs market has witnessed a meaningful surge over the years, due to the rising awareness concerning veterinary care. Growing urbanization and increasing number of pet animals are anticipated to influence the growth of the veterinary dermatology drugs market. The rising ubiquity of atopic dermatitis among animals is significantly demanding better veterinary drugs. The world, especially guardians and owners of pets, is learning about veterinary skin disorders, treatment options, and various government initiatives to increase farm animal productivity. In addition, increasing population of companion animals and compliance to spend for their healthcare are assisting in the global market growth during the forecast period. The global veterinary dermatology drugs market is projected to expand at a moderate CAGR from 2021 to 2031.
North America holds the major share of the veterinary dermatology drugs market, owing to the high prevalence of pruritus, sores, alopecia, masses, eruptions, scales, seborrhea, pustules, and draining tracts in animals, and is expected to continue its dominance during the forecast period. Followed by North America, Europe is expected to hold a significant position in the veterinary dermatology drugs market, due to the various new dermatological association in the European region, which is increasing awareness about skin diseases in animals. Furthermore, this market in Asia Pacific is likely to be driven by the increased adoption of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region.
Analysts’ Viewpoint
The expanding awareness about available skin treatment choices and the growing incidences of skin problems such as atopic dermatitis are driving the global veterinary dermatology drugs market. Governments of various nations are taking initiatives to improve productivity of farm animals by investing in veterinary drugs. As ointments and creams are easily accessible and simple to use, they are expected to dominate the skincare segment of the veterinary dermatology drugs market. The market is currently witnessing a slowdown due to strict government regulations due to the ongoing pandemic. However, with veterinarians taking proper measures and providing contactless services, the global veterinary dermatology drugs market is projected to overcome the current restraints in the upcoming future.
Veterinary dermatology drugs market to surpass valuation Of US$ 9.9 Bn by 2031
Veterinary dermatology drugs market is driven by increase in medical and diagnostic capabilities for companion animals
North America accounted for a major share of the global veterinary dermatology drugs market
The antibacterial drugs segment dominated the global veterinary dermatology drugs market, owing to high prevalence of bacterial infection among animals
Key players operating in the global veterinary dermatology drugs market are Merial, Zoetis, Inc., Ceva Sante Animale, Vetmedica, IDEXX Laboratories, Vetoquinol S.A.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Dermatology Drugs Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary Dermatology Drugs Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Regulatory Scenario by Region/globally
5.3. Cost of Veterinary Dermatological treatments
5.4. List of Veterinary Dermatological Products Manufacturing Facilities, by Key Region
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
6.3.1. Antifungal Drugs
6.3.2. Antibacterial Drugs
6.3.3. Antiparasitic Drugs
6.3.4. Others
6.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type
7. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
7.3.1. Topical
7.3.2. Oral
7.3.3. Injectable
7.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration
8. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Animal Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
8.3.1. Large Animals
8.3.1.1. Equine
8.3.1.2. Bovine
8.3.1.3. Others
8.3.2. Small Animals
8.3.2.1. Cat
8.3.2.2. Dogs
8.3.2.3. Others
8.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type
9. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
9.3.1. Infectious Diseases
9.3.2. Skin Cancer
9.3.3. Autoimmune Skin Diseases
9.3.4. Parasitic Infections
9.3.5. Others
9.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication
10. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Region
11. North America Veterinary Dermatology Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
11.2.1. Antifungal Drugs
11.2.2. Antibacterial Drugs
11.2.3. Antiparasitic Drugs
11.2.4. Others
11.3. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
11.3.1. Oral
11.3.2. Topical
11.3.3. Injectable
11.4. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
11.4.1. Large Animals
11.4.1.1. Equine
11.4.1.2. Bovine
11.4.1.3. Others
11.4.2. Small Animals
11.4.2.1. Cat
11.4.2.2. Dogs
11.4.2.3. Others
11.5. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
11.5.1. Infectious Diseases
11.5.2. Skin Cancer
11.5.3. Autoimmune Skin Diseases
11.5.4. Parasitic Infections
11.5.5. Others
11.6. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. North America Veterinary Dermatology Drugs Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Mode of Administration
11.7.3. By Animal Type
11.7.4. By Indication
11.7.5. By Country
12. Europe Veterinary Dermatology Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
12.2.1. Antifungal Drugs
12.2.2. Antibacterial Drugs
12.2.3. Antiparasitic Drugs
12.2.4. Others
12.3. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
12.3.1. Oral
12.3.2. Topical
12.3.3. Injectable
12.4. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
12.4.1. Large Animals
12.4.1.1. Equine
12.4.1.2. Bovine
12.4.1.3. Others
12.4.2. Small Animals
12.4.2.1. Cat
12.4.2.2. Dogs
12.4.2.3. Others
12.5. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
12.5.1. Infectious Diseases
12.5.2. Skin Cancer
12.5.3. Autoimmune Skin Diseases
12.5.4. Parasitic Infections
12.5.5. Others
12.6. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Veterinary Dermatology Drugs Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Mode of Administration
12.7.3. By Animal Type
12.7.4. By Indication
12.7.5. By Country/Sub-region
13. Asia Pacific Veterinary Dermatology Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
13.2.1. Antifungal Drugs
13.2.2. Antibacterial Drugs
13.2.3. Antiparasitic Drugs
13.2.4. Others
13.3. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
13.3.1. Oral
13.3.2. Topical
13.3.3. Injectable
13.4. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
13.4.1. Large Animals
13.4.1.1. Equine
13.4.1.2. Bovine
13.4.1.3. Others
13.4.2. Small Animals
13.4.2.1. Cat
13.4.2.2. Dogs
13.4.2.3. Others
13.5. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
13.5.1. Infectious Diseases
13.5.2. Skin Cancer
13.5.3. Autoimmune Skin Diseases
13.5.4. Parasitic Infections
13.5.5. Others
13.6. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Mode of Administration
13.7.3. By Animal Type
13.7.4. By Indication
13.7.5. By Country/Sub-region
14. Latin America Veterinary Dermatology Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
14.2.1. Antifungal Drugs
14.2.2. Antibacterial Drugs
14.2.3. Antiparasitic Drugs
14.2.4. Others
14.3. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
14.3.1. Oral
14.3.2. Topical
14.3.3. Injectable
14.4. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
14.4.1. Large Animals
14.4.1.1. Equine
14.4.1.2. Bovine
14.4.1.3. Others
14.4.2. Small Animals
14.4.2.1. Cat
14.4.2.2. Dogs
14.4.2.3. Others
14.5. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
14.5.1. Infectious Diseases
14.5.2. Skin Cancer
14.5.3. Autoimmune Skin Diseases
14.5.4. Parasitic Infections
14.5.5. Others
14.6. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Mode of Administration
14.7.3. By Animal Type
14.7.4. By Indication
14.7.5. By Country/Sub-region
15. Middle East & Africa Veterinary Dermatology Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
15.2.1. Antifungal Drugs
15.2.2. Antibacterial Drugs
15.2.3. Antiparasitic Drugs
15.2.4. Others
15.3. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
15.3.1. Oral
15.3.2. Topical
15.3.3. Injectable
15.4. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
15.4.1. Large Animals
15.4.1.1. Equine
15.4.1.2. Bovine
15.4.1.3. Others
15.4.2. Small Animals
15.4.2.1. Cat
15.4.2.2. Dogs
15.4.2.3. Others
15.5. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
15.5.1. Infectious Diseases
15.5.2. Skin Cancer
15.5.3. Autoimmune Skin Diseases
15.5.4. Parasitic Infections
15.5.5. Others
15.6. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Mode of Administration
15.7.3. By Animal Type
15.7.4. By Indication
15.7.5. By Country/Sub-region
16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Bayer
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Bimeda, Inc.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Boehringer Ingelheim GmbH
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Ceva Santé Animale
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Eli Lilly and Company
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. Merck Animal Health
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Sanofi S.A.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Virbac
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Zoetis, Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
List of Tables
Table 01: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 03: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 04: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 05: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 06: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 10: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 11: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 12: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 13: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 14: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 17: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 18: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 19: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 20: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 21: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 22: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 23: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 24: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 25: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 26: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 27: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 28: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 29: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 30: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 31: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 32: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 33: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 34: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 35: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 37: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 38: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 39: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 40: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 41: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 42: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
List of Figures
Figure 01: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 03: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 04: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Antifungal Drugs, 2017–2031
Figure 05: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Antibacterial Drugs, 2017–2031
Figure 06: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Antiparasitic Drugs, 2017–2031
Figure 07: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Others, 2017–2031
Figure 08: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031
Figure 09: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031
Figure 10: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Topical, 2017–2031
Figure 11: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Oral, 2017–2031
Figure 12: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Injectable, 2017–2031
Figure 13: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031
Figure 14: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031
Figure 15: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Large Animals, 2017–2031
Figure 16: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Small Animals, 2017–2031
Figure 17: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031
Figure 18: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031
Figure 19: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Infectious Diseases, 2017–2031
Figure 20: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Skin Cancer, 2017–2031
Figure 21: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Autoimmune Skin Diseases, 2017–2031
Figure 22: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Parasitic Infections, 2017–2031
Figure 23: Global Veterinary Dermatology Drugs Market Revenue (US$ Mn), by Other, 2017–2031
Figure 24: Global Veterinary Dermatology Drugs Market Value Share Analysis, by Region, 2020 and 2031
Figure 25: Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Region, 2021–2031
Figure 26: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031
Figure 27: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Country, 2020 and 2031
Figure 28: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country, 2021–2031
Figure 29: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 30: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 31: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031
Figure 32: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031
Figure 33: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031
Figure 34: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031
Figure 35: North America Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031
Figure 36: North America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031
Figure 37: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 39: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 40: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 41: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 42: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031
Figure 43: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031
Figure 44: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031
Figure 45: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031
Figure 46: Europe Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031
Figure 47: Europe Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031
Figure 48: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031
Figure 49: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 50: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 51: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 52: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 53: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031
Figure 54: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031
Figure 55: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031
Figure 56: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031
Figure 57: Asia Pacific Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031
Figure 58: Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031
Figure 59: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031
Figure 60: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 61: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 62: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 63: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 64: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031
Figure 65: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031
Figure 66: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031
Figure 67: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031
Figure 68: Latin America Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031
Figure 69: Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031
Figure 70: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, 2017–2031
Figure 71: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 72: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 73: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 74: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 75: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Mode of Administration, 2020 and 2031
Figure 76: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration, 2021–2031
Figure 77: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Animal Type, 2020 and 2031
Figure 78: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type, 2021–2031
Figure 79: Middle East & Africa Veterinary Dermatology Drugs Market Value Share Analysis, by Indication, 2020 and 2031
Figure 80: Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Veterinary Dermatology Drugs Market
